A federal judge has ruled that Watson Pharmaceuticals (WPI) CEO Paul Bisaro must sit for an FTC deposition about his pay-for-delay dealings with Cephalon (CEPH), ending his long, conspicuous silence ...

When former Allergan CEO Paul Bisaro became CEO of small and struggling Impax Laboratories, investors wondered if he would institute the same mix of aggressive M&A and consolidation that allowed him ...

More turnover is coming to Allergan’s board—and this time, it’s the man who arguably built the company. Paul Bisaro, one-time CEO and chairman of the company and its leader through multiple iterations ...

FLORHAM PARK, N.J.--(BUSINESS WIRE)--Zoetis Inc. (NYSE:ZTS) today announced that its Board of Directors has appointed Paul M. Bisaro, Executive Chairman of Actavis plc, to the company's Board of ...

Roula Khalaf, Editor of the FT, selects her favourite stories in this weekly newsletter. Paul Bisaro, the outspoken chief executive of drugs company Actavis, has quickly gained a reputation as an ...

Welcome to this week's Chutes & Ladders, our roundup of hirings, firings and retirings throughout the industry. Please send the good word—or the bad—from your shop to Kyle Blankenship, and we will ...